Neurochemical basis of cannabis addiction
- PMID: 21334423
- DOI: 10.1016/j.neuroscience.2011.02.035
Neurochemical basis of cannabis addiction
Abstract
Cannabis derivatives have become the most widely used illicit substances in developed countries, and constitute a major health concern. The psychoactive compounds contained in cannabis induce their pharmacological effects by the activation of at least two different receptors, CB1 and CB2 cannabinoid receptors. Multiple studies have demonstrated the specific involvement of CB1 cannabinoid receptors in the addictive properties of cannabinoids. Several neurotransmitter systems involved in the addictive effects of other prototypical drugs of abuse, such as the dopaminergic and the opioid system are also involved in cannabis addiction. The participation of other neurochemical systems in behavioural responses of cannabinoids related to their addictive effects has also been reported. This review describes the experimental methods now available to study the pharmacological responses of cannabinoids related to their addictive effects and how these methods have contributed to advance the knowledge of the specific contribution of different neurochemical systems in cannabis addiction.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Cannabis: pharmacology and toxicology in animals and humans.Addiction. 1996 Nov;91(11):1585-614. Addiction. 1996. PMID: 8972919 Review.
-
Cannabinoid tolerance and dependence: a review of studies in laboratory animals.Pharmacol Biochem Behav. 2005 Jun;81(2):300-18. doi: 10.1016/j.pbb.2005.01.028. Pharmacol Biochem Behav. 2005. PMID: 15919107 Review.
-
The neurobiology and evolution of cannabinoid signalling.Philos Trans R Soc Lond B Biol Sci. 2001 Mar 29;356(1407):381-408. doi: 10.1098/rstb.2000.0787. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11316486 Free PMC article. Review.
-
Basic neuroanatomy and neuropharmacology of cannabinoids.Int Rev Psychiatry. 2009 Apr;21(2):113-21. doi: 10.1080/09540260902782760. Int Rev Psychiatry. 2009. PMID: 19367505 Review.
-
Cannabinoid addiction: behavioral models and neural correlates.J Neurosci. 2002 May 1;22(9):3326-31. doi: 10.1523/JNEUROSCI.22-09-03326.2002. J Neurosci. 2002. PMID: 11978807 Free PMC article. Review.
Cited by
-
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease.Front Neurosci. 2016 May 31;10:243. doi: 10.3389/fnins.2016.00243. eCollection 2016. Front Neurosci. 2016. PMID: 27303261 Free PMC article. Review.
-
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far.Front Neurosci. 2013 Dec 20;7:256. doi: 10.3389/fnins.2013.00256. Front Neurosci. 2013. PMID: 24391536 Free PMC article. Review.
-
Terpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systems.ACS Chem Neurosci. 2014 Nov 19;5(11):1097-106. doi: 10.1021/cn5000875. Epub 2014 Jun 5. ACS Chem Neurosci. 2014. PMID: 24866555 Free PMC article. Review.
-
Mechanisms Underlying Sex Differences in Cannabis Use.Curr Addict Rep. 2017 Dec;4(4):439-453. doi: 10.1007/s40429-017-0174-7. Epub 2017 Oct 19. Curr Addict Rep. 2017. PMID: 29503790 Free PMC article.
-
Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.Iran J Pharm Res. 2021 Fall;20(4):152-164. doi: 10.22037/ijpr.2021.114918.15106. Iran J Pharm Res. 2021. PMID: 35194436 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical